Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 2/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.39 |
| ▸ | SCD | O00767 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | CBFB | Q13951 | 1/20 | 0.36 |
| ▸ | GPR39 | O43194 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6590005 | 0.80 | PTGS2 (0.43) | ESR2PTGS2PTGS1 | |
| SCHEMBL6470491 | 0.77 | PTGS2 (0.41) | ESR2PTGS2PTGS1 | |
| SCHEMBL6441194 | 0.76 | PTGS2 (0.46) | ESR2PTGS2PTGS1 | |
| SCHEMBL6438018 | 0.74 | PTGS2 (0.43) | ESR2PTGS2PTGS1 | |
| SCHEMBL3865463 | 0.73 | ESR2 (0.49) | ESR2PTGS2PTGS1 | |
| SCHEMBL6440855 | 0.71 | PTGS2 (0.42) | ESR2PTGS2PTGS1 | |
| SCHEMBL4958540 | 0.71 | PTGS2 (0.44) | ESR2PTGS2PTGS1 | |
| SCHEMBL6438240 | 0.71 | PTGS2 (0.48) | ESR2PTGS2PTGS1 | |
| SCHEMBL6441773 | 0.71 | PTGS2 (0.40) | ESR2PTGS2PTGS1 | |
| SCHEMBL5150520 | 0.71 | ESR2 (0.47) | ESR2PTGS2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1534683-A4 | CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE | NITROMED INC (US) | 2005-08-24 | — | — | EP | disclosed |
| EP-1534683-A2 | CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2005-06-01 | — | — | EP | disclosed |
| WO-2004002409-A2 | CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2004-01-08 | — | — | WO | disclosed |